Can New Blood Test Predict Alzheimer’s Disease?
Researchers from the University of Washington developed a laboratory test that can measure toxic amyloid proteins – known as amyloid beta oligomers – in blood samples and potentially detect Alzheimer’s disease years before symptoms develop.
Why Is Chris Hemsworth More Likely to Develop Alzheimer’s Disease?
Chris Hemsworth underwent genetic testing for an episode of his docuseries Limitless — and found out he has an 8 to 10 times greater chance of getting Alzheimer’s.
Does Mediterranean Diet Reduce Dementia Risk?
Following a well-balanced diet that’s rich in fruits and vegetables and low in sugar can have many benefits to your health, including reducing a person’s risk of dementia. However, a popular and well-recommended meal plan known as the Mediterranean diet may not lower the odds of developing dementia as previous research had suggested.
What are the Early Signs of Dementia?
Here are some common medical problems that can be mistaken for dementia.
Are There Less Restrictive Alternatives to Guardianship
Although laws vary from state to state, every state requires that less restrictive alternatives be considered before invoking a guardianship. These might include such vehicles as limited guardianships, powers of attorney or assisted decision-making agreements.
Research News in Finding a Cure for Alzheimer’s
More than 40 genes have been linked to Alzheimer’s disease for the first time, in a “landmark” study offering hope for better diagnosis and treatment.
Worried an Elderly Parent Is Being Scammed?
In the wake of the coronavirus pandemic, many older adults are more socially isolated than ever—and thus more vulnerable to being financially victimized.
Is Palliative Care Only Pain Management?
The COVID pandemic has shown how palliative care can also be valuable for managing the pain and stress of illness.
What Does UK Study Say about Dementia Patients Seeing the Same Doctor?
Study finds patients who consistently see same GP have fewer health complications and emergency hospital visits.
What’s the Latest on Controversial New Alzheimer’s Drug Aduhelm?
Medicare officials have decided that the federal health insurance program should only cover the controversial new Alzheimer’s drug Aduhelm for patients who are participating in approved clinical trials. The preliminary decision, reached after lengthy deliberations, was released on Tuesday by the Center for Medicare and Medicaid Services, or C.M.S. If it is finalized later this year, it would significantly limit the number of patients who could use the expensive drug.